STTR Phase I: Oral Cancer Detection Using Redox Magnetohydrodynamic Microfluidics-based Bioassay Chips

Period of Performance: 01/01/2007 - 12/31/2007


Phase 1 STTR

Recipient Firm

SFC Fluidics, LLC
Fayetteville, AR 72701
Principal Investigator
Firm POC

Research Institution

University of Pennsylvania
3330 Walnut Street, Levine hal
Philadelphia, PA 19104
Institution POC


This Small Business Technology Transfer Research (STTR) Phase I project aims to develop a molecular signature-based redox magnetohydrodynamic (MHD) microfluidic system for the detection of oral cancer. The microfluidic chips are expected to interface with a handheld readout instrument that has a low operator skill requirement and is suited for point-of-care operation.If successful, the methodology can be used for early detection of oral squamous cell carcinoma, as well as other forms of cancer and as such may benefit a large number of individuals suffering from cancer.